Month: <span>August 2022</span>

Home / 2022 / August
What to know about the rise of flesh-eating bacteria cases
Post

What to know about the rise of flesh-eating bacteria cases

by Morayo Ogunbayo  Credit: CC0 Public Domain Cases of flesh-eating bacteria, which refer to any tissue-destroying infection, rise in summer when more people are cooling off in bodies of water. The most common bacteria, vibrio, is often found in seawater and has the potential to be deadly. The infection can come from swimming in waters...

Post

Retractions are increasing, but not enough

Ivan Oransky When my colleague Adam Marcus, editorial director at Medscape, and I launched the blog Retraction Watch in 2010, we didn’t realize we were riding a wave. At the time, we thought journals were issuing about three retractions per month. But that hadn’t been true for a decade. In 2010, they were averaging about...

Post

VR balance training is highly effective in improving balance ability of patients with Parkinson’s disease

Reviewed by Emily Henderson, B.Sc. Aug 2 2022 JMIR Publications recently published “Benefits of Virtual Reality Balance Training for Patients With Parkinson Disease: Systematic Review, Meta-analysis, and Meta-Regression of a Randomized Controlled Trial” in JMIR Serious Games, which reported that virtual reality (VR) balance training is increasingly being pursued in biomedical research, specifically with respect to investigating...

Post

Scientists ‘spray paint’ cells to reveal secret genes

Many of the thousands of proteins that help our cells grow and function remain undiscovered, especially the tiniest ones that occupy what some Yale scientists call the “dark matter” of our genome. While thousands of these lesser-known “microproteins” have recently been identified, many more remain elusive, and even less is known about their roles and functions. With...

Post

The Brain’s Drainage System in 3 Dimensions

Meningeal lymphatic vessels are potential targets for treating brain diseases. Laboratories at Yale and the Paris Brain Institute (Pitié-Salpêtrière Hospital, Paris) image brain drainage by meningeal lymphatics in mice and in humans. The recent Journal of Experimental Medicine paper led by Jean-Leon Thomas, PhD, professor of neurology, and Anne Eichmann, PhD, Ensign Professor of Medicine and professor of cellular and...

Spray Coating Fights Viruses and Bacteria
Post

Spray Coating Fights Viruses and Bacteria

AUGUST 1ST, 2022 CONN HASTINGS MATERIALS, PUBLIC HEALTH Researchers at the University of Sydney in Australia engineered a new spray coating for surfaces that provides long-term protection against bacterial and viral contamination. The material is intended as a long-term alternative to disinfectant sprays and combines hydrophobic properties with antimicrobial nanoparticles to reduce microbial contamination.  The...

Using light to restore cell function
Post

Using light to restore cell function

UNIVERSITY OF CINCINNATI IMAGE: JIAJIE DIAO, PHD, WORKS IN HIS LAB. CREDIT: PHOTO/COLLEEN KELLEY/UC MARKETING + BRAND. New research from the University of Cincinnati shows early indications that light can be used as a treatment for certain diseases, including cancer. Researchers from UC, the University of Illinois Urbana-Champaign and the University at Buffalo published the...

Scientists uncover new therapeutic target for treating colorectal tumors
Post

Scientists uncover new therapeutic target for treating colorectal tumors

TOKYO UNIVERSITY OF SCIENCE IMAGE: A NEW STUDY BY RESEARCHERS FROM JAPAN AND CHINA HAS REVEALED THAT INHIBITING DCIR, A C-TYPE LECTIN RECEPTOR PROTEIN RESPONSIBLE FOR MAINTAINING HOMEOSTASIS IN THE IMMUNE AND BONE SYSTEMS, REDUCES THE SEVERITY OF DSS COLITIS SYMPTOMS AND SUPPRESSES COLORECTAL TUMOR GROWTH. THESE FINDINGS COULD PAVE THE WAY FOR THERAPEUTIC STRATEGIES...

New viral vectors for targeted gene therapy of heart muscle cells
Post

New viral vectors for targeted gene therapy of heart muscle cells

by Medizinische Hochschule Hannover  Graphical abstract. Credit: Molecular Therapy (2022). DOI: 10.1016/j.ymthe.2022.07.003 Gene therapies aim to cure severe, barely treatable monogentic diseases caused by a defect in a single gene. Medical hopes are correspondingly high. Some gene therapies have already been approved in Europe—for example, for spinal muscular atrophy (SMA), a congenital neuromuscular disease with severe muscle...